Mutual of America Capital Management LLC Buys 1,445 Shares of Centene Co. (NYSE:CNC)

Mutual of America Capital Management LLC lifted its stake in Centene Co. (NYSE:CNC) by 1.5% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 98,022 shares of the company’s stock after purchasing an additional 1,445 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Centene were worth $7,379,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Swedbank AB bought a new stake in shares of Centene in the 1st quarter worth about $914,080,000. Boston Partners boosted its position in shares of Centene by 0.4% during the first quarter. Boston Partners now owns 8,652,177 shares of the company’s stock valued at $678,033,000 after buying an additional 32,427 shares during the period. Bank of New York Mellon Corp grew its stake in shares of Centene by 0.5% during the second quarter. Bank of New York Mellon Corp now owns 5,491,968 shares of the company’s stock valued at $364,117,000 after buying an additional 25,595 shares during the last quarter. Capital International Investors lifted its stake in shares of Centene by 60.2% during the 1st quarter. Capital International Investors now owns 5,216,486 shares of the company’s stock worth $409,390,000 after acquiring an additional 1,959,460 shares during the last quarter. Finally, Legal & General Group Plc boosted its holdings in Centene by 14.2% during the 2nd quarter. Legal & General Group Plc now owns 5,113,759 shares of the company’s stock valued at $339,042,000 after acquiring an additional 636,683 shares during the period. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on CNC shares. Barclays decreased their target price on Centene from $97.00 to $91.00 and set an “overweight” rating for the company in a research report on Tuesday, October 29th. Oppenheimer reduced their target price on shares of Centene from $110.00 to $95.00 and set an “outperform” rating on the stock in a research report on Monday, July 29th. Stephens restated an “equal weight” rating and set a $78.00 price objective on shares of Centene in a report on Monday, August 5th. TD Cowen upped their target price on Centene from $80.00 to $89.00 and gave the stock a “buy” rating in a report on Wednesday, July 31st. Finally, Robert W. Baird decreased their price objective on Centene from $83.00 to $66.00 and set a “neutral” rating for the company in a report on Friday, October 25th. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $83.92.

Centene Stock Up 2.4 %

Shares of Centene stock opened at $58.83 on Tuesday. Centene Co. has a 52-week low of $57.20 and a 52-week high of $81.42. The firm’s 50 day moving average price is $67.82 and its 200-day moving average price is $70.88. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64. The company has a market cap of $29.70 billion, a P/E ratio of 10.21, a PEG ratio of 0.79 and a beta of 0.49.

Insider Transactions at Centene

In related news, CFO Andrew Lynn Asher acquired 17,200 shares of the firm’s stock in a transaction that occurred on Wednesday, November 13th. The stock was purchased at an average cost of $58.14 per share, with a total value of $1,000,008.00. Following the transaction, the chief financial officer now directly owns 486,847 shares of the company’s stock, valued at $28,305,284.58. This trade represents a 3.66 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Sarah London bought 4,117 shares of the company’s stock in a transaction on Friday, November 8th. The shares were bought at an average cost of $60.80 per share, for a total transaction of $250,313.60. Following the transaction, the chief executive officer now owns 667,229 shares in the company, valued at $40,567,523.20. The trade was a 0.62 % increase in their position. The disclosure for this purchase can be found here. Insiders own 0.33% of the company’s stock.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.